| 8001 | Weight (minimum, inv-normal transformed) | GCST90476466 | 0.10 |
| 8002 | DAB2/FKBP5 ratio | GCST90314363 | 0.10 |
| 8003 | white blood cell count (WBC, minimum, inv-norm transformed) | GCST90476457 | 0.10 |
| 8004 | wg lh intensity-contrast paracentral | GCST90003808 | 0.10 |
| 8005 | BMI (weighted GWA) | GCST90267269 | 0.10 |
| 8006 | Cholesterol in IDL (UKB data field 23526) | GCST90269623 | 0.10 |
| 8007 | MMP9/OLR1 ratio | GCST90315467 | 0.10 |
| 8008 | BPIFA2 levels | GCST90468461 | 0.10 |
| 8009 | Phosphatidylcholine acyl-alkyl C36:5 levels | GCST90240073 | 0.10 |
| 8010 | APP/VEGFC ratio | GCST90313333 | 0.10 |
| 8011 | Disorders of lipoprotein metabolism and other lipidaemias | Metabolic disorders | UKBB00000186 | 0.10 |
| 8012 | Glycated hemoglobin levels | GCST90002243 | 0.10 |
| 8013 | SPINT2/TNFSF13 ratio | GCST90315879 | 0.10 |
| 8014 | DTI TBSS MD Anterior limb of internal capsule L | GCST90384589 | 0.10 |
| 8015 | Takes medication for migraine headaches? | GCST90475547 | 0.10 |
| 8016 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T275 | ECGA000275 | 0.10 |
| 8017 | Hayfever | GCST90468131 | 0.10 |
| 8018 | AKT1S1/MAX ratio | GCST90313230 | 0.10 |
| 8019 | Docosahexaenoic acid to total fatty acids percentage | GCST90501991 | 0.10 |
| 8020 | Hyperlipidemia | endocrine/metabolic | UKBB00000333 | 0.10 |
| 8021 | Worry too long after an embarrassing experience | GCST006946 | 0.10 |
| 8022 | Concentration of HDL particles | GCST90497414 | 0.10 |
| 8023 | T1 FreeSurfer DK lh precuneus volume | GCST90385680 | 0.10 |
| 8024 | PAEP/RSPO1 ratio | GCST90315593 | 0.10 |
| 8025 | PSCA levels | GCST90470352 | 0.10 |
| 8026 | Total fatty acid levels | GCST90502220 | 0.10 |
| 8027 | Methods of admission to hospital (recoded) - Elective admission: Waiting List | Summary Administration | UKBB00000463 | 0.10 |
| 8028 | Stress incontinence, female | genitourinary | UKBB00000797 | 0.10 |
| 8029 | Graves' disease (PheCode 242.1) | GCST90475644 | 0.10 |
| 8030 | Other disorders of amino-acid metabolism | FING00001014 | 0.09 |
| 8031 | Liver fat | GCST90029073 | 0.09 |
| 8032 | CD28 levels | GCST90468616 | 0.09 |
| 8033 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T471 | ECGA000471 | 0.09 |
| 8034 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T275 | ECGU000275 | 0.09 |
| 8035 | Free cholesterol in very small VLDL (UKB data field 23521) | GCST90269618 | 0.09 |
| 8036 | Total lipid levels in very small VLDL | GCST90093034 | 0.09 |
| 8037 | Free cholesterol in small HDL (UKB data field 23577) | GCST90269674 | 0.09 |
| 8038 | Cardiac conduction disorders (PheCode 426) | GCST90475952 | 0.09 |
| 8039 | C2 levels | GCST90468497 | 0.09 |
| 8040 | Physical activity (Principal component 2) | GCST90061423 | 0.09 |
| 8041 | Diacylglycerol_44:6_[M+H-H2O]1+ levels | GCST90060245 | 0.09 |
| 8042 | KDR levels | GCST90243323 | 0.09 |
| 8043 | PSME2 levels | GCST90470361 | 0.09 |
| 8044 | Salmon liking | GCST90094826 | 0.09 |
| 8045 | CELA3A levels | GCST90468702 | 0.09 |
| 8046 | Other disorders of synovium, tendon, and bursa (PheCode 727) | GCST90476241 | 0.09 |
| 8047 | LPO levels | GCST90241730 | 0.09 |
| 8048 | Volume of right central nucleus | GCST90475024 | 0.09 |
| 8049 | IDP dMRI ProbtrackX ISOVF atr l | GCST90004527 | 0.09 |
| 8050 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T273 | ECGU000273 | 0.09 |
| 8051 | Cognitive processing accuracy | GCST90446169 | 0.09 |
| 8052 | HPGDS levels | GCST90469472 | 0.09 |
| 8053 | Biological Mother: Cancer, Skin | GCST90475487 | 0.09 |
| 8054 | IDP dMRI TBSS ICVF Superior fronto-occipital fasciculus R | GCST90004369 | 0.09 |
| 8055 | IDP dMRI TBSS OD Body of corpus callosum | GCST90004405 | 0.09 |
| 8056 | CLEC1B/PPP1R2 ratio | GCST90314101 | 0.09 |
| 8057 | ATOX1 levels | GCST90468385 | 0.09 |
| 8058 | White blood cell count | GCST90002374 | 0.09 |
| 8059 | CCL26 levels | GCST90468578 | 0.09 |
| 8060 | Docosahexaenoic acid to total fatty acids percentage | GCST90502269 | 0.09 |
| 8061 | AGRP/CCN1 ratio | GCST90313202 | 0.09 |
| 8062 | MRC1 levels | GCST90469939 | 0.09 |
| 8063 | Saturated fatty acids levels | GCST90502658 | 0.09 |
| 8064 | FOLH1 levels | GCST90425661 | 0.09 |
| 8065 | Non-cancer illness code, self-reported - hiatus hernia | Medical conditions | UKBB00000515 | 0.09 |
| 8066 | Mean platelet volume during first trimester of pregnancy | GCST90302229 | 0.09 |
| 8067 | Activities undertaken to treat depression | Depression | UKBB00000010 | 0.09 |
| 8068 | Right-hemisphere limbic network to putamen white-matter structural connectivity | GCST90302829 | 0.09 |
| 8069 | Hidradenitis suppurativa | FING00000621 | 0.09 |
| 8070 | CNTN4 levels | GCST90240786 | 0.09 |
| 8071 | CTRC/KIRREL2 ratio | GCST90314309 | 0.09 |
| 8072 | GSN levels | GCST90469409 | 0.09 |
| 8073 | Severe autoimmune type 2 diabetes | GCST90026412 | 0.09 |
| 8074 | MAP2K6/NT5C3A ratio | GCST90315374 | 0.09 |
| 8075 | Total lipids in very small VLDL | GCST90500813 | 0.09 |
| 8076 | Phosphoglycerides levels (UKB data field 23434) | GCST90269531 | 0.09 |
| 8077 | Granulocyte percentage of myeloid white cells | GCST004608 | 0.09 |
| 8078 | Atrial flutter (PheCode 427.22) | GCST90475973 | 0.09 |
| 8079 | GAS6 levels | GCST90469305 | 0.09 |
| 8080 | Concentration of large LDL particles (UKB data field 23530) | GCST90269627 | 0.09 |
| 8081 | rfMRI connectivity (ICA100 edge 931) | GCST90005784 | 0.09 |
| 8082 | Triglyceride levels | GCST90278645 | 0.09 |
| 8083 | COCH levels | GCST90468810 | 0.09 |
| 8084 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T207 | ECGU000207 | 0.09 |
| 8085 | Principal component-derived dietary pattern 33 | GCST90133038 | 0.09 |
| 8086 | SELPLG levels | GCST90470568 | 0.09 |
| 8087 | Phospholipids in IDL (UKB data field 23525) | GCST90269622 | 0.09 |
| 8088 | Hyperplasia of prostate | FING00000635 | 0.09 |
| 8089 | GP1BA/SDC4 ratio | GCST90314957 | 0.09 |
| 8090 | Phospholipid levels in medium VLDL | GCST90092924 | 0.09 |
| 8091 | mean platelet volume (MPV, maximum, inv-norm transformed) | GCST90475517 | 0.09 |
| 8092 | Concentration of medium VLDL particles | GCST90092923 | 0.09 |
| 8093 | VAT1 levels | GCST90471029 | 0.09 |
| 8094 | EDAR/SDC4 ratio | GCST90314585 | 0.09 |
| 8095 | Dissociative [conversion] disorders | FING00000468 | 0.09 |
| 8096 | ANGPT1/EGF ratio | GCST90313264 | 0.09 |
| 8097 | Zoster infection | GCST90018721 | 0.09 |
| 8098 | PAPPA levels | GCST90012036 | 0.09 |
| 8099 | FABP4/FGF21 ratio | GCST90314758 | 0.09 |
| 8100 | HippSubfield rh volume Hippocampal-tail | GCST90002690 | 0.09 |
| 8101 | Vertiginous syndromes and other disorders of vestibular system (PheCode 386) | GCST90475905 | 0.09 |
| 8102 | Diabetes / Sugar | GCST90475265 | 0.09 |
| 8103 | LGALS7 or LGALS7B levels | GCST90469763 | 0.09 |
| 8104 | Staphylococcus A fleurettii abundance in stool | GCST90032564 | 0.09 |
| 8105 | Concentration of very small VLDL particles (UKB data field 23516) | GCST90269613 | 0.09 |
| 8106 | Arm fat percentage left (UKB data field 23123) | GCST90468157 | 0.09 |
| 8107 | Luteinizing hormone levels | GCST90483478 | 0.09 |
| 8108 | MZB1 levels | GCST90469987 | 0.09 |
| 8109 | Abnormal results of function study of liver (PheCode 573.7) | GCST90476097 | 0.09 |
| 8110 | Free cholesterol to total lipids in small VLDL percentage (UKB data field 23602) | GCST90269699 | 0.09 |
| 8111 | CTSV levels | GCST90468917 | 0.09 |
| 8112 | Left ventricular mass (indexed to body surface area) | GCST90435260 | 0.09 |
| 8113 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T397 | ECGU000397 | 0.09 |
| 8114 | IDP dMRI TBSS ICVF Cerebral peduncle L | GCST90004342 | 0.09 |
| 8115 | Coagulation defects (PheCode 286) | GCST90475796 | 0.09 |
| 8116 | Right ventricular end diastolic volume | GCST90134588 | 0.09 |
| 8117 | Triacylglycerol_52:1_[M+NH4]1+ levels | GCST90060515 | 0.09 |
| 8118 | GOLM2/ITGA5 ratio | GCST90314951 | 0.09 |
| 8119 | DNA methylation Hannum age acceleration | GCST90014289 | 0.09 |
| 8120 | Type 1 diabetes | GCST90014023 | 0.09 |
| 8121 | GZMA/LTA ratio | GCST90315012 | 0.09 |
| 8122 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T430 | ECGU000430 | 0.09 |
| 8123 | CD209/GP2 ratio | GCST90313751 | 0.09 |
| 8124 | Propionylglycine levels | GCST90199705 | 0.09 |
| 8125 | aparc-Desikan lh volume superiorparietal | GCST90002796 | 0.09 |
| 8126 | Migraine | FING00000818 | 0.09 |
| 8127 | CD58/MCAM ratio | GCST90313852 | 0.09 |
| 8128 | Rheumatoid arthritis and other inflammatory polyarthropathies | musculoskeletal | UKBB00000758 | 0.09 |
| 8129 | PFKFB2/SRP14 ratio | GCST90315650 | 0.09 |
| 8130 | Vaginitis/vulvovaginitis/vulvitis/abscess of vulva | FING00001412 | 0.09 |
| 8131 | Type 2 diabetes | GCST90468151 | 0.09 |
| 8132 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T445 | ECGU000445 | 0.09 |
| 8133 | rfMRI amplitudes (ICA100 node 11) | GCST90004599 | 0.09 |
| 8134 | DTI autoptx L1 ptr l tract | GCST90385158 | 0.09 |
| 8135 | CD46/SELP ratio | GCST90313834 | 0.09 |
| 8136 | SLC35G2 levels | GCST90242857 | 0.09 |
| 8137 | BST2/CXADR ratio | GCST90313538 | 0.09 |
| 8138 | Cholesterol to total lipids in small HDL percentage (UKB data field 23645) | GCST90269742 | 0.09 |
| 8139 | CPM levels | GCST90468843 | 0.09 |
| 8140 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T277 | ECGU000277 | 0.09 |
| 8141 | Estrone 3-sulfate metabolite level | GCST90616383 | 0.09 |
| 8142 | Duration of walks | Physical activity | UKBB00000200 | 0.09 |
| 8143 | CDHR2/SSC4D ratio | GCST90313965 | 0.09 |
| 8144 | Spread type - Butter/spreadable butter | Diet | UKBB00000793 | 0.09 |
| 8145 | Free Cholesterol to Total Lipids in Medium VLDL percentage | GCST90498988 | 0.09 |
| 8146 | DYNLT1 levels | GCST90469057 | 0.09 |
| 8147 | DCXR levels | GCST90468964 | 0.09 |
| 8148 | Total concentration of lipoprotein particles | GCST90092990 | 0.09 |
| 8149 | Docosahexaenoic acid levels | GCST90502255 | 0.09 |
| 8150 | Disorders of lipoid metabolism | endocrine/metabolic | UKBB00000185 | 0.09 |
| 8151 | Omega-3 fatty acid levels | GCST90502437 | 0.09 |
| 8152 | Alcohol drinker status: current or former vs never (UKB data field 20117) | GCST90132923 | 0.09 |
| 8153 | Concentration of VLDL particles | GCST90093000 | 0.09 |
| 8154 | Plays computer games | Electronic device use | UKBB00000649 | 0.09 |
| 8155 | Vitamin D | Blood biochemistry | UKBB00000902 | 0.09 |
| 8156 | Operation code - bilateral oophorectomy | Operations | UKBB00000550 | 0.09 |
| 8157 | Transport type for commuting to job workplace - Public transport | Employment | UKBB00000828 | 0.09 |
| 8158 | AKT1S1/FHIT ratio | GCST90313228 | 0.09 |
| 8159 | S100A13 levels | GCST90470514 | 0.09 |
| 8160 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T474 | ECGA000474 | 0.09 |
| 8161 | Total cholesterol minus HDL-C levels | GCST90499130 | 0.09 |
| 8162 | Free cholesterol to total lipids in IDL percentage (UKB data field 23612) | GCST90269709 | 0.09 |
| 8163 | 1-arachidonoylglycerophosphoinositol levels | GCST90243754 | 0.09 |
| 8164 | Chronic bronchitis | respiratory | UKBB00000136 | 0.09 |
| 8165 | Reaction time (standard GWA) | GCST90267296 | 0.09 |
| 8166 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T274 | ECGU000274 | 0.09 |
| 8167 | Acute alcohol intoxication | FING00000014 | 0.09 |
| 8168 | Triglycerides to total lipids in small VLDL percentage (UKB data field 23603) | GCST90269700 | 0.09 |
| 8169 | EPCAM/GPA33 ratio | GCST90314674 | 0.09 |
| 8170 | Salt added to food | Diet | UKBB00000762 | 0.09 |
| 8171 | RGMB/THY1 ratio | GCST90315771 | 0.09 |
| 8172 | Principal component-derived dietary pattern 35 | GCST90133040 | 0.09 |
| 8173 | Hearing loss (PheCode 389) | GCST90475909 | 0.09 |
| 8174 | Cholesterol to total lipids ratio in large VLDL | GCST90092869 | 0.09 |
| 8175 | Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers) | FING00000768 | 0.09 |
| 8176 | DTI autoptx FA ifo l tract | GCST90385124 | 0.09 |
| 8177 | SIT1 levels | GCST90470644 | 0.09 |
| 8178 | CALCB levels | GCST90468529 | 0.09 |
| 8179 | wg lh intensity-contrast medialorbitofrontal | GCST90003805 | 0.09 |
| 8180 | BA-exvivo lh area BA1 | GCST90003207 | 0.09 |
| 8181 | MGAT2 levels | GCST90089560 | 0.09 |
| 8182 | Saturated fatty acids to total fatty acids percentage | GCST90502701 | 0.09 |
| 8183 | Left-hemisphere visual network to left-hemisphere limbic network white-matter structural connectivity | GCST90302652 | 0.09 |
| 8184 | Phosphatidylcholine_35:2_[M+H]1+/Phosphatidylethanolamine_38:2_[M+H]1+/Phosphatidate_40:3_[M+NH4]1+ levels | GCST90060325 | 0.09 |
| 8185 | UCMA levels | GCST90243285 | 0.09 |
| 8186 | TGFA levels | GCST90470842 | 0.09 |
| 8187 | IDP T1 FIRST brain stem+4th ventricle volume | GCST90002450 | 0.09 |
| 8188 | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) levels | GCST90199858 | 0.09 |
| 8189 | T1 FreeSurfer a2009s rh Pole occipital area | GCST90384931 | 0.09 |
| 8190 | LPCAT2 levels | GCST90469787 | 0.09 |
| 8191 | TMSB10/TREML2 ratio | GCST90315923 | 0.09 |
| 8192 | COLEC12/TAFA5 ratio | GCST90314185 | 0.09 |
| 8193 | TYMP levels | GCST90470996 | 0.09 |
| 8194 | aparc-Desikan rh area caudalmiddlefrontal | GCST90003110 | 0.09 |
| 8195 | Hemoglobin concentration | GCST90002311 | 0.09 |
| 8196 | IDP dMRI TBSS L2 Body of corpus callosum | GCST90004126 | 0.09 |
| 8197 | Prostate cancer | GCST90018685 | 0.09 |
| 8198 | APOB levels | GCST90269536 | 0.09 |
| 8199 | CALCOCO1/IRAG2 ratio | GCST90313604 | 0.09 |
| 8200 | FHIT/MAX ratio | GCST90314818 | 0.09 |
| 8201 | KYNU levels | GCST90469722 | 0.09 |
| 8202 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T206 | ECGU000206 | 0.09 |
| 8203 | Uterine leiomyomata | GCST90239856 | 0.09 |
| 8204 | NCR1 levels | GCST90470009 | 0.09 |
| 8205 | PDGFB/PPP1R12A ratio | GCST90315623 | 0.09 |
| 8206 | estimated glomerular filtration rate (eGFR, maximum, inv-norm transformed) | GCST90475280 | 0.09 |
| 8207 | Oily fish consumption | GCST90132993 | 0.09 |
| 8208 | Left-hemisphere salience/ventral attention network to amygdala white-matter structural connectivity | GCST90302724 | 0.09 |
| 8209 | IL7R levels | GCST90469605 | 0.09 |
| 8210 | Gestational thrombocytopenia | GCST90302234 | 0.09 |
| 8211 | CST3 levels | UKBB00000163 | 0.09 |
| 8212 | Crohn's disease of large intestine | FING00000368 | 0.09 |
| 8213 | Phospholipids to total lipids in small VLDL percentage (UKB data field 23599) | GCST90269696 | 0.09 |
| 8214 | Heart rate variability (corrected root mean square of successive differences) | GCST90281264 | 0.09 |
| 8215 | DDAH1 levels | GCST90468966 | 0.09 |
| 8216 | TNFRSF9 levels | GCST90470916 | 0.09 |
| 8217 | GLOD4/S100A4 ratio | GCST90314944 | 0.08 |
| 8218 | SPINT2 levels | GCST90470728 | 0.08 |
| 8219 | Triglycerides to total lipids in medium VLDL percentage (UKB data field 23598) | GCST90269695 | 0.08 |
| 8220 | Atrial fibrillation (MTAG) | GCST90449054 | 0.08 |
| 8221 | CD84/CDKN1A ratio | GCST90313909 | 0.08 |
| 8222 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T175 | ECGU000175 | 0.08 |
| 8223 | Skin brightness | GCST90502777 | 0.08 |
| 8224 | Free cholesterol to total lipids ratio in large LDL | GCST90092861 | 0.08 |
| 8225 | Total lipid levels in medium VLDL | GCST90092922 | 0.08 |
| 8226 | T1 FreeSurfer DK rh cuneus area | GCST90385693 | 0.08 |
| 8227 | estimated glomerular filtration rate (eGFR, minimum, inv-norm transformed) | GCST90475285 | 0.08 |
| 8228 | NQO2 levels | GCST90242679 | 0.08 |
| 8229 | Time spent driving | Physical activity | UKBB00000818 | 0.08 |
| 8230 | ICA1/MVK ratio | GCST90315108 | 0.08 |
| 8231 | Gamma glutamyltransferase | Blood biochemistry | UKBB00000275 | 0.08 |
| 8232 | GFRA2/IL12A_IL12B ratio | GCST90314925 | 0.08 |
| 8233 | Physical activity (standard GWA) | GCST90267292 | 0.08 |
| 8234 | Endometriosis diagnosis and infertility diagnosis occurring together | FING00000499 | 0.08 |
| 8235 | Non-cancer illness year/age first occurred | Medical conditions | UKBB00000523 | 0.08 |
| 8236 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T129 | ECGU000129 | 0.08 |
| 8237 | Cardiovascular delta age (difference between ECG-predicted and chronological age) | GCST90239749 | 0.08 |
| 8238 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T221 | ECGA000221 | 0.08 |
| 8239 | GZMB/IL15 ratio | GCST90315015 | 0.08 |
| 8240 | Glycoprotein acetyls levels (UKB data field 23480) | GCST90269577 | 0.08 |
| 8241 | LRG1 levels | GCST90469793 | 0.08 |
| 8242 | GFAP levels | GCST90469325 | 0.08 |
| 8243 | GP2/SELE ratio | GCST90314962 | 0.08 |
| 8244 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T222 | ECGA000222 | 0.08 |
| 8245 | DTI autoptx MD ptr l tract | GCST90385239 | 0.08 |
| 8246 | TAX1BP3 levels | GCST90242976 | 0.08 |
| 8247 | PLA2G4A levels | GCST90470248 | 0.08 |
| 8248 | DAG1/DBNL ratio | GCST90314372 | 0.08 |
| 8249 | aparc-a2009s rh volume G-occipital-sup | GCST90003018 | 0.08 |
| 8250 | LAG3 levels | GCST90469727 | 0.08 |
| 8251 | PSAPL1 levels | GCST90470350 | 0.08 |
| 8252 | T1 CAT volume R SupramarginalGyrusanteriordivision | GCST90384037 | 0.08 |
| 8253 | High light scatter reticulocyte count (UKB data field 30300) | GCST90468076 | 0.08 |
| 8254 | CDKN2D/ITGB1BP2 ratio | GCST90313987 | 0.08 |
| 8255 | platelet count (minimum, inv-norm transformed) | GCST90476302 | 0.08 |
| 8256 | GALNT10 levels | GCST90469295 | 0.08 |
| 8257 | FKBP5/MITD1 ratio | GCST90314844 | 0.08 |
| 8258 | Parental longevity (combined parental age at death) | GCST006702 | 0.08 |
| 8259 | Total lipids in small LDL (UKB data field 23545) | GCST90269642 | 0.08 |
| 8260 | CIAPIN1/PLA2G4A ratio | GCST90314065 | 0.08 |
| 8261 | LGALS3BP levels | GCST90469760 | 0.08 |
| 8262 | ERP44/SUMF2 ratio | GCST90314710 | 0.08 |
| 8263 | Hemoglobin | GCST90018737 | 0.08 |
| 8264 | Monocyte count | GCST90002393 | 0.08 |
| 8265 | Linoleic acid levels | GCST90502307 | 0.08 |
| 8266 | Sphingomyelin_34:2_[M+H]1+ levels | GCST90060235 | 0.08 |
| 8267 | Free cholesterol in small VLDL (UKB data field 23514) | GCST90269611 | 0.08 |
| 8268 | ThalamNuclei rh volume MDl | GCST90002748 | 0.08 |
| 8269 | T1 FreeSurfer DKT rh lateraloccipital volume | GCST90384357 | 0.08 |
| 8270 | Triglycerides to total lipids ratio in very small VLDL | GCST90093039 | 0.08 |
| 8271 | Mild obesity-related type 2 diabetes | GCST90026415 | 0.08 |
| 8272 | TANK levels | GCST90470803 | 0.08 |
| 8273 | X-11444 metabolite level | GCST90616545 | 0.08 |
| 8274 | Total lipids in very small VLDL (UKB data field 23517) | GCST90269614 | 0.08 |
| 8275 | Coxarthrosis [arthrosis of hip] | Arthrosis | UKBB00000154 | 0.08 |
| 8276 | ANGPT1/CPXM1 ratio | GCST90313262 | 0.08 |
| 8277 | Principal component-derived dietary pattern 23 | GCST90133028 | 0.08 |
| 8278 | DAPP1/PTPN6 ratio | GCST90314397 | 0.08 |
| 8279 | IDP dMRI TBSS OD External capsule L | GCST90004435 | 0.08 |
| 8280 | IDP dMRI TBSS L1 Anterior limb of internal capsule L | GCST90004092 | 0.08 |
| 8281 | hemoglobin (maximum, inv-norm transformed) | GCST90475372 | 0.08 |
| 8282 | FCRL2 levels | GCST90469206 | 0.08 |
| 8283 | Allergic disease (asthma, hay fever or eczema) | GCST005038 | 0.08 |
| 8284 | Total cholesterol levels (UKB data field 23400) | GCST90269497 | 0.08 |
| 8285 | Sleep apnea | GCST90475257 | 0.08 |
| 8286 | FCRL5/TNFRSF13B ratio | GCST90314805 | 0.08 |
| 8287 | B4GALT1/SPON2 ratio | GCST90313434 | 0.08 |
| 8288 | aparc-DKTatlas rh area caudalmiddlefrontal | GCST90003267 | 0.08 |
| 8289 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T432 | ECGU000432 | 0.08 |
| 8290 | Average log acceleration during the five least active hours of the day | GCST90061431 | 0.08 |
| 8291 | F10 levels | GCST90469163 | 0.08 |
| 8292 | Tea without sugar liking | GCST90094858 | 0.08 |
| 8293 | Red cell distribution width | GCST004621 | 0.08 |
| 8294 | Reticulocyte percentage | Blood count | UKBB00000753 | 0.08 |
| 8295 | Nontoxic uninodular goiter (PheCode 241.1) | GCST90475640 | 0.08 |
| 8296 | Total lipid levels in small VLDL | GCST90092974 | 0.08 |
| 8297 | Urate levels | GCST001791 | 0.08 |
| 8298 | Mood swings | Mental health | UKBB00000482 | 0.08 |
| 8299 | X-21736 levels | GCST90200584 | 0.08 |
| 8300 | Other disorders of stomach and duodenum (PheCode 537) | GCST90476054 | 0.08 |
| 8301 | VCAM1 levels | GCST90471031 | 0.08 |
| 8302 | HippSubfield rh volume presubiculum-head | GCST90002695 | 0.08 |
| 8303 | F-sweet food liking (derived food-liking factor) | GCST90094854 | 0.08 |
| 8304 | Concentration of LDL particles (UKB data field 23429) | GCST90269526 | 0.08 |
| 8305 | Bitter ale liking | GCST90094705 | 0.08 |
| 8306 | MMP12 levels | GCST90469916 | 0.08 |
| 8307 | Other (seronegative) rheumatoid arthritis, wide | FING00000917 | 0.08 |
| 8308 | T1 FreeSurfer DK rh superiorparietal thickness | GCST90385751 | 0.08 |
| 8309 | F2R/MPIG6B ratio | GCST90314732 | 0.08 |
| 8310 | GSTA1/RBP5 ratio | GCST90314995 | 0.08 |
| 8311 | EPPK1 levels | GCST90469137 | 0.08 |
| 8312 | Whole grain cereal liking | GCST90094869 | 0.08 |
| 8313 | Alcohol drinker status: current vs never (UKB data field 20117) | GCST90132924 | 0.08 |
| 8314 | GP6/HPCAL1 ratio | GCST90314963 | 0.08 |
| 8315 | Triglycerides in very large HDL (UKB data field 23557) | GCST90269654 | 0.08 |
| 8316 | 3,5-dichloro-2,6-dihydroxybenzoic acid levels | GCST90200252 | 0.08 |
| 8317 | Spondylosis without myelopathy (PheCode 721.1) | GCST90476236 | 0.08 |
| 8318 | Polycystic ovarian syndrome | FING00001182 | 0.08 |
| 8319 | In your lifetime, have you smoked a total of at least 100 cigarettes? | GCST90476387 | 0.08 |
| 8320 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T186 | ECGA000186 | 0.08 |
| 8321 | Feeling worry | GCST006950 | 0.08 |
| 8322 | Cholesterol to total lipids ratio in medium LDL | GCST90092905 | 0.08 |
| 8323 | Melanocytic naevi | FING00000797 | 0.08 |
| 8324 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T241 | ECGU000241 | 0.08 |
| 8325 | EGLN1 levels | GCST90469087 | 0.08 |
| 8326 | Sleep duration | GCST003839 | 0.08 |
| 8327 | Ceramide (d18:2/22:0) levels | GCST90024054 | 0.08 |
| 8328 | Crohn's disease | GCST004132 | 0.08 |
| 8329 | CDSN/LY6D ratio | GCST90313997 | 0.08 |
| 8330 | F-fish liking (derived food-liking factor) | GCST90094762 | 0.08 |
| 8331 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T102 | ECGU000102 | 0.08 |
| 8332 | aseg global volume CC-Central | GCST90002609 | 0.08 |
| 8333 | ERBIN/SIRT2 ratio | GCST90314696 | 0.08 |
| 8334 | Tea difference liking | GCST90094855 | 0.08 |
| 8335 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T463 | ECGU000463 | 0.08 |
| 8336 | DNMBP/TBC1D5 ratio | GCST90314519 | 0.08 |
| 8337 | Biological Mother: Cancer, Breast | GCST90475485 | 0.08 |
| 8338 | Abnormal movement (PheCode 350) | GCST90475840 | 0.08 |
| 8339 | Free cholesterol in medium HDL | GCST90498563 | 0.08 |
| 8340 | Concentration of medium LDL particles (UKB data field 23537) | GCST90269634 | 0.08 |
| 8341 | BA-exvivo rh area BA2 | GCST90003222 | 0.08 |
| 8342 | SELP/VSIR ratio | GCST90315822 | 0.08 |
| 8343 | Alkylphosphatidylcholine (O-34:1) levels | GCST90025551 | 0.08 |
| 8344 | Tense / 'highly strung' | Mental health | UKBB00000815 | 0.08 |
| 8345 | PIK3IP1/RGMB ratio | GCST90315652 | 0.08 |
| 8346 | Bladder stone | GCST90468116 | 0.08 |
| 8347 | MITD1/WWP2 ratio | GCST90315458 | 0.08 |
| 8348 | Attention deficit hyperactivity disorder | GCST005362 | 0.08 |
| 8349 | HSD11B1 levels | GCST90469482 | 0.08 |
| 8350 | Free cholesterol in large LDL (UKB data field 23535) | GCST90269632 | 0.08 |
| 8351 | IPCEF1 levels | GCST90469624 | 0.08 |
| 8352 | Worry too long after embarrassment | Mental health | UKBB00000922 | 0.08 |
| 8353 | Smoking status - Previous | Smoking | UKBB00000781 | 0.08 |
| 8354 | Omega-3 fatty acid levels | GCST90502055 | 0.08 |
| 8355 | Calcium levels (UKB data field 30680) | GCST90468065 | 0.08 |
| 8356 | MED18/SH2B3 ratio | GCST90315412 | 0.08 |
| 8357 | DPEP2 levels | GCST90469031 | 0.08 |
| 8358 | Stool frequency | GCST90002250 | 0.08 |
| 8359 | Monocyte count (UKB data field 30130) | GCST90468090 | 0.08 |
| 8360 | aparc-a2009s rh volume Pole-occipital | GCST90003040 | 0.08 |
| 8361 | CD93/CLEC14A ratio | GCST90313921 | 0.08 |
| 8362 | GRAP2/LACTB2 ratio | GCST90314980 | 0.08 |
| 8363 | IDP dMRI ProbtrackX OD slf l | GCST90004471 | 0.08 |
| 8364 | T1 FreeSurfer DK rh lateraloccipital volume | GCST90385767 | 0.08 |
| 8365 | Monounsaturated fatty acid levels | GCST90502358 | 0.08 |
| 8366 | Triglycerides | GCST90018755 | 0.08 |
| 8367 | Diseases of the digestive system | FING00000429 | 0.08 |
| 8368 | FADD/GRAP2 ratio | GCST90314766 | 0.08 |
| 8369 | Volume of right cortical nucleus | GCST90475033 | 0.08 |
| 8370 | Phosphatidylcholine (18:0_20:3) levels | GCST90024876 | 0.08 |
| 8371 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T282 | ECGU000282 | 0.08 |
| 8372 | CFI levels | GCST90468730 | 0.08 |
| 8373 | Blood urea nitrogen (BUN, maximum, inv-norm transformed) | GCST90475162 | 0.08 |
| 8374 | Left bundle-branch block | FING00000716 | 0.08 |
| 8375 | Polyunsaturated fatty acid levels | GCST90502619 | 0.08 |
| 8376 | Oily fish intake | Diet | UKBB00000547 | 0.08 |
| 8377 | Takes medication for enlarged prostate (Benign prostatic hyperplasia)? | GCST90475262 | 0.08 |
| 8378 | eGFR in diabetes mellitus (loose) kidney healthy controls (full adjustment) | GCST90624793 | 0.08 |
| 8379 | Frailty (Factor 5 - Poorer Cognition) | GCST90624051 | 0.08 |
| 8380 | Free cholesterol in medium VLDL | GCST90498965 | 0.08 |
| 8381 | CD302/IL12A_IL12B ratio | GCST90313806 | 0.08 |
| 8382 | AXIN1/MAP2K6 ratio | GCST90313413 | 0.08 |
| 8383 | Number of vehicles in household | Household | UKBB00000543 | 0.08 |
| 8384 | RNF149 levels | GCST90470482 | 0.08 |
| 8385 | creatinine (maximum, inv-norm transformed) | GCST90475226 | 0.08 |
| 8386 | Intrinsic epigenetic age acceleration | GCST90014290 | 0.08 |
| 8387 | HippSubfield lh volume subiculum-body | GCST90002669 | 0.08 |
| 8388 | DFFA/SIRT2 ratio | GCST90314462 | 0.08 |
| 8389 | Hyperlipidemia | GCST90090994 | 0.08 |
| 8390 | Defects in the complement system | FING00000383 | 0.08 |
| 8391 | Urine taurocholenate sulfate* levels in chronic kidney disease | GCST90266041 | 0.08 |
| 8392 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T174 | ECGU000174 | 0.08 |
| 8393 | IL1RAP levels | GCST90469573 | 0.08 |
| 8394 | Illnesses of siblings - High blood pressure | Family history | UKBB00000352 | 0.08 |
| 8395 | Estradiol levels | GCST90020091 | 0.08 |
| 8396 | Total fatty acid levels | GCST90502726 | 0.08 |
| 8397 | F-sodas liking (derived food-liking factor) | GCST90094842 | 0.08 |
| 8398 | IDO1 levels | GCST90469506 | 0.08 |
| 8399 | CLEC14A/TNFRSF21 ratio | GCST90314082 | 0.08 |
| 8400 | Left-hemisphere control network to left-hemisphere default mode network white-matter structural connectivity | GCST90302744 | 0.08 |
| 8401 | AXIN1/INPPL1 ratio | GCST90313410 | 0.08 |
| 8402 | Qualifications - A levels/AS levels or equivalent | Education | UKBB00000727 | 0.08 |
| 8403 | Phosphatidylcholine_36:5_[M+H]1+/Phosphatidylethanolamine_39:5_[M+H]1+/Phosphatidate_41:6_[M+NH4]1+ levels | GCST90060345 | 0.08 |
| 8404 | Pollen allergy | FING00001176 | 0.08 |
| 8405 | EBI3_IL27/VCAM1 ratio | GCST90314572 | 0.08 |
| 8406 | Free cholesterol in small HDL | GCST90499411 | 0.08 |
| 8407 | SELL levels | GCST90470567 | 0.08 |
| 8408 | CD163 levels | GCST90468600 | 0.08 |
| 8409 | HMOX2 levels | GCST90469466 | 0.08 |
| 8410 | SPARC/TACC3 ratio | GCST90315872 | 0.08 |
| 8411 | TNFSF10 levels | GCST90274843 | 0.08 |
| 8412 | Right ventricular stroke volume (MTAG) | GCST90134594 | 0.08 |
| 8413 | FUT8/PDGFA ratio | GCST90314890 | 0.08 |
| 8414 | MLN/TNFRSF12A ratio | GCST90315459 | 0.08 |
| 8415 | T1 FreeSurfer BA lh BA4p exvivo thickness | GCST90385524 | 0.08 |
| 8416 | Triglycerides in HDL (UKB data field 23410) | GCST90269507 | 0.08 |
| 8417 | DKK1/MGLL ratio | GCST90314473 | 0.08 |
| 8418 | Triglycerides in LDL (UKB data field 23409) | GCST90269506 | 0.08 |
| 8419 | platelet count (mean, inv-norm transformed) | GCST90476299 | 0.08 |
| 8420 | X-21364 levels | GCST90200566 | 0.08 |
| 8421 | Rhodanobacter abundance in stool | GCST90032536 | 0.08 |
| 8422 | Triacylglycerol_54:7_[M+NH4]1+ levels | GCST90060536 | 0.08 |
| 8423 | Psoriasis | GCST90019016 | 0.08 |
| 8424 | Free cholesterol to total lipids ratio in small HDL | GCST90092949 | 0.08 |
| 8425 | Obstructive sleep apnea (PheCode 327.32) | GCST90475825 | 0.08 |
| 8426 | Free cholesterol to total lipids in medium VLDL percentage (UKB data field 23597) | GCST90269694 | 0.08 |
| 8427 | Carotid artery plaque burden | GCST90503076 | 0.08 |
| 8428 | Gastric cancer | GCST90018629 | 0.08 |
| 8429 | Anterior diffusion tensor imaging along the perivascular space index | GCST90455543 | 0.08 |
| 8430 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T205 | ECGU000205 | 0.08 |
| 8431 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T172 | ECGU000172 | 0.08 |
| 8432 | Cholesteryl esters in very small VLDL (UKB data field 23520) | GCST90269617 | 0.08 |
| 8433 | Time spent outdoors in winter | Sun exposure | UKBB00000819 | 0.08 |
| 8434 | Pneumoconiosis due to other inorganic dusts | FING00001173 | 0.08 |
| 8435 | EFNA4/TNFRSF10B ratio | GCST90314605 | 0.07 |
| 8436 | Triglycerides to total lipids ratio in medium LDL | GCST90092915 | 0.07 |
| 8437 | Octadecenedioate (C18:1-DC) levels | GCST90200165 | 0.07 |
| 8438 | CLPP/DECR1 ratio | GCST90314137 | 0.07 |
| 8439 | CKAP4/LAMP3 ratio | GCST90314073 | 0.07 |
| 8440 | T1 FreeSurfer DK rh lingual area | GCST90385701 | 0.07 |
| 8441 | CA4 levels | GCST90468513 | 0.07 |
| 8442 | Triglycerides x depression interaction (2df test) | GCST90570679 | 0.07 |
| 8443 | creatinine (mean, inv-norm transformed) | GCST90475229 | 0.07 |
| 8444 | Glucose (fasting status unknown, maximum, inv-norm transformed) | GCST90475329 | 0.07 |
| 8445 | FBP1 levels | GCST90469195 | 0.07 |
| 8446 | Total fatty acid levels | GCST90502722 | 0.07 |
| 8447 | IDP dMRI TBSS ICVF Middle cerebellar peduncle | GCST90004327 | 0.07 |
| 8448 | N-acetylphenylalanine levels in chronic kidney disease | GCST90257537 | 0.07 |
| 8449 | aparc-DKTatlas rh area supramarginal | GCST90003294 | 0.07 |
| 8450 | Serum 25-Hydroxyvitamin D levels | GCST90000618 | 0.07 |
| 8451 | PSAPL1 levels | GCST90242354 | 0.07 |
| 8452 | PACS2 levels | GCST90470141 | 0.07 |
| 8453 | Citrate levels | GCST90497206 | 0.07 |
| 8454 | Substance abuse (more control exclusions) | FING00001341 | 0.07 |
| 8455 | AXIN1/CLIP2 ratio | GCST90313404 | 0.07 |
| 8456 | Diastolic blood pressure, manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000181 | 0.07 |
| 8457 | SIGLEC1/SSC5D ratio | GCST90315844 | 0.07 |
| 8458 | Blood cell traits latent factor 23 (white cell) | GCST90559265 | 0.07 |
| 8459 | CANT1/NUDT5 ratio | GCST90313619 | 0.07 |
| 8460 | HippSubfield rh volume GC-ML-DG-body | GCST90002703 | 0.07 |
| 8461 | Reticulocyte percentage (UKB data field 30240) | GCST90468101 | 0.07 |
| 8462 | IL1RN levels | GCST90012004 | 0.07 |
| 8463 | CDH6 levels | GCST90468677 | 0.07 |
| 8464 | aparc-a2009s rh area G-precuneus | GCST90003400 | 0.07 |
| 8465 | IDP dMRI TBSS ICVF Superior fronto-occipital fasciculus L | GCST90004370 | 0.07 |
| 8466 | FADD/MGLL ratio | GCST90314768 | 0.07 |
| 8467 | Prospective memory result | Prospective memory | UKBB00000713 | 0.07 |
| 8468 | FCER2/TREML2 ratio | GCST90314792 | 0.07 |
| 8469 | creatinine (minimum, inv-norm transformed) | GCST90475232 | 0.07 |
| 8470 | ACY3 levels | GCST90468213 | 0.07 |
| 8471 | Two-hour glucose | GCST90002227 | 0.07 |
| 8472 | Principal component-derived dietary pattern 10 | GCST90133015 | 0.07 |
| 8473 | CCL20 levels | GCST90468572 | 0.07 |
| 8474 | Phosphatidylcholine levels | GCST90499240 | 0.07 |
| 8475 | BTN3A2 levels | GCST90468481 | 0.07 |
| 8476 | DTI TBSS L2 Anterior limb of internal capsule R | GCST90384492 | 0.07 |
| 8477 | Sardines liking | GCST90094830 | 0.07 |
| 8478 | TIMD4 levels | GCST90470866 | 0.07 |
| 8479 | CASP3/LYN ratio | GCST90313635 | 0.07 |
| 8480 | Free cholesterol in large HDL | GCST90497786 | 0.07 |
| 8481 | IFNGR1 levels | GCST90469513 | 0.07 |
| 8482 | Gestational [pregnancy-induced] hypertension | FING00000571 | 0.07 |
| 8483 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T438 | ECGU000438 | 0.07 |
| 8484 | CEP85 levels | GCST90468716 | 0.07 |
| 8485 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 25) | GCST90320588 | 0.07 |
| 8486 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T447 | ECGU000447 | 0.07 |
| 8487 | Erythronate levels | GCST90243696 | 0.07 |
| 8488 | White blood cell count | GCST004610 | 0.07 |
| 8489 | CLPS levels | GCST90468786 | 0.07 |
| 8490 | Estradiol levels | GCST90012105 | 0.07 |
| 8491 | COMMD1 levels | GCST90468825 | 0.07 |
| 8492 | aparc-Desikan lh area superiorparietal | GCST90003101 | 0.07 |
| 8493 | Hair colour (natural, before greying): Light brown (UKB data field 1747_3) | GCST90041838 | 0.07 |
| 8494 | IDP dMRI TBSS L1 Cingulum cingulate gyrus R | GCST90004109 | 0.07 |
| 8495 | SERPINB1/SERPINB9 ratio | GCST90315827 | 0.07 |
| 8496 | IDP dMRI TBSS FA Uncinate fasciculus L | GCST90003922 | 0.07 |
| 8497 | aparc-pial rh area precentral | GCST90003197 | 0.07 |
| 8498 | Docosahexaenoic acid levels | GCST90501978 | 0.07 |
| 8499 | FADD/LACTB2 ratio | GCST90314767 | 0.07 |
| 8500 | CEP43/TIA1 ratio | GCST90314021 | 0.07 |
| 8501 | IDP T1 FAST ROIs L thalamus | GCST90002547 | 0.07 |
| 8502 | CCDC50 levels | GCST90468561 | 0.07 |
| 8503 | Sodium in urine | Urine assays | UKBB00000785 | 0.07 |
| 8504 | Operative procedures - Unspecified diagnostic endoscopic examination of colon | Summary Operations | UKBB00000591 | 0.07 |
| 8505 | LAMP2 levels | GCST90469734 | 0.07 |
| 8506 | AmygNuclei lh volume Accessory-Basal-nucleus | GCST90002650 | 0.07 |
| 8507 | Mean arterial pressure, manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000444 | 0.07 |
| 8508 | ENG/TNFRSF10C ratio | GCST90314650 | 0.07 |
| 8509 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 67) | GCST90320886 | 0.07 |
| 8510 | CSF1R levels | GCST90468880 | 0.07 |
| 8511 | IDP dMRI TBSS FA Body of corpus callosum | GCST90003880 | 0.07 |
| 8512 | Noninfectious gastroenteritis | digestive | UKBB00000526 | 0.07 |
| 8513 | Principal component-derived dietary pattern 13 | GCST90133018 | 0.07 |
| 8514 | DTI autoptx L1 slf l tract | GCST90385160 | 0.07 |
| 8515 | T1 FreeSurfer BA rh V1 exvivo area | GCST90385556 | 0.07 |
| 8516 | CRADD/STAMBP ratio | GCST90314244 | 0.07 |
| 8517 | Other disorders of skin and subcutaneous tissue | FING00001035 | 0.07 |
| 8518 | Omega-6 fatty acids to total fatty acids percentage | GCST90502544 | 0.07 |
| 8519 | Diastolic blood pressure, manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000182 | 0.07 |
| 8520 | CD74/JAM2 ratio | GCST90313893 | 0.07 |
| 8521 | N-delta-acetylornithine levels | GCST90200691 | 0.07 |
| 8522 | Invitation to complete online 24-hour recall dietary questionnaire, acceptance | Online follow-up - Diet by 24-hour recall | UKBB00000378 | 0.07 |
| 8523 | Other enthesopathies | FING00001045 | 0.07 |
| 8524 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 10) | GCST90320829 | 0.07 |
| 8525 | Lysophosphatidylcholine_16:1_[M+H]1+/Lysophosphatidylethanolamine_19:1_[M+H]1+ levels | GCST90060148 | 0.07 |
| 8526 | Pancreas volume | GCST90016669 | 0.07 |
| 8527 | Cholesteryl Esters to Total Lipids in Medium LDL percentage | GCST90498758 | 0.07 |
| 8528 | Postinfectious hypothyroidism | FING00001192 | 0.07 |
| 8529 | Cholesteryl esters in medium LDL (UKB data field 23541) | GCST90269638 | 0.07 |
| 8530 | Lymphocyte percentage of white cells | GCST004632 | 0.07 |
| 8531 | Modified Stumvoll Insulin Sensitivity Index | GCST90267574 | 0.07 |
| 8532 | Mean platelet volume at delivery | GCST90302232 | 0.07 |
| 8533 | KLK8 levels | GCST90241680 | 0.07 |
| 8534 | Blood urea nitrogen levels | GCST90018728 | 0.07 |
| 8535 | Never eat eggs, dairy, wheat, sugar - Sugar or foods/drinks containing sugar | Diet | UKBB00000501 | 0.07 |
| 8536 | Atrial fibrillation | GCST006414 | 0.07 |
| 8537 | monocyte (fraction, mean, inv-norm transformed) | GCST90475511 | 0.07 |
| 8538 | GUSB levels | GCST90469421 | 0.07 |
| 8539 | HAO1 levels | GCST90469429 | 0.07 |
| 8540 | SMPDL3A levels | GCST90470686 | 0.07 |
| 8541 | IDP dMRI TBSS L3 Body of corpus callosum | GCST90004174 | 0.07 |
| 8542 | PLA2G4A/SNX9 ratio | GCST90315670 | 0.07 |
| 8543 | ICD10 N87: Dysplasia of cervix uteri | GCST90454218 | 0.07 |
| 8544 | Red cell distribution width | GCST90002369 | 0.07 |
| 8545 | Cholesterol to total lipids in large HDL percentage (UKB data field 23635) | GCST90269732 | 0.07 |
| 8546 | High cholesterol | GCST90475205 | 0.07 |
| 8547 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T276 | ECGA000276 | 0.07 |
| 8548 | ITGB2 levels | GCST90469644 | 0.07 |
| 8549 | Omega-6 fatty acid levels | GCST90502515 | 0.07 |
| 8550 | aparc-pial lh area superiorparietal | GCST90003169 | 0.07 |
| 8551 | Low density lipoprotein cholesterol levels | GCST90002412 | 0.07 |
| 8552 | Degree of unsaturation | GCST90502753 | 0.07 |
| 8553 | IDP T1 FAST ROIs R postcent gyrus | GCST90002484 | 0.07 |
| 8554 | Vegetarianism | GCST90428838 | 0.07 |
| 8555 | (R)-3-hydroxybutyrylcarnitine levels | GCST90199930 | 0.07 |
| 8556 | Body mass index (BMI, minimum, inv-normal transformed) | GCST90475159 | 0.07 |
| 8557 | Heart failure with reduced EF [Systolic or combined heart failure] (PheCode 428.3) | GCST90475983 | 0.07 |
| 8558 | Total lipids in medium LDL (UKB data field 23538) | GCST90269635 | 0.07 |
| 8559 | APP/NID1 ratio | GCST90313326 | 0.07 |
| 8560 | General happiness with own health | Happiness and subjective well-being | UKBB00000281 | 0.07 |
| 8561 | Cholesterol to total lipids ratio in large LDL | GCST90092857 | 0.07 |
| 8562 | CDCP1 levels | GCST90468667 | 0.07 |
| 8563 | BACH1/EIF4G1 ratio | GCST90313438 | 0.07 |
| 8564 | GP5 levels | GCST90469383 | 0.07 |
| 8565 | CA4/SELE ratio | GCST90313587 | 0.07 |
| 8566 | GCHFR levels | GCST90469317 | 0.07 |
| 8567 | DSG4/FABP9 ratio | GCST90314562 | 0.07 |
| 8568 | CLIC5 levels | GCST90421740 | 0.07 |
| 8569 | CRADD/HSPA1A ratio | GCST90314239 | 0.07 |
| 8570 | CXCL3 levels | GCST90468931 | 0.07 |
| 8571 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502414 | 0.07 |
| 8572 | Nontoxic nodular goiter (PheCode 241) | GCST90475638 | 0.07 |
| 8573 | TDGF1 levels | GCST90470824 | 0.07 |
| 8574 | NAGPA levels | GCST90242004 | 0.07 |
| 8575 | Incidence of bisecting GlcNAc in all fucosylated disialylated structures (GP57) | GCST90668735 | 0.07 |
| 8576 | Cancer code, self-reported: breast cancer (UKB data field 20001_1002) | GCST90041886 | 0.07 |
| 8577 | IDP dMRI ProbtrackX ISOVF ilf r | GCST90004540 | 0.07 |
| 8578 | TNFRSF10B levels | GCST90012021 | 0.07 |
| 8579 | Right-hemisphere visual network to hippocampus white-matter structural connectivity | GCST90302785 | 0.07 |
| 8580 | PODXL2/SDC1 ratio | GCST90315701 | 0.07 |
| 8581 | ABHD14B levels | GCST90468189 | 0.07 |
| 8582 | Polyunsaturated fatty acids to total fatty acids percentage | GCST90499302 | 0.07 |
| 8583 | ITM2A levels | GCST90469653 | 0.07 |
| 8584 | Other cancer | GCST90475181 | 0.07 |
| 8585 | N6-acetyllysine levels in chronic kidney disease | GCST90257531 | 0.07 |
| 8586 | Triglycerides in medium LDL (UKB data field 23543) | GCST90269640 | 0.07 |
| 8587 | Total concentration of lipoprotein particles | GCST90500101 | 0.07 |
| 8588 | Cholelithiasis | GCST90468118 | 0.07 |
| 8589 | CDSN levels | GCST90468688 | 0.07 |
| 8590 | Wegener granulomatosis | FING00001446 | 0.07 |
| 8591 | neutrophil (absolute count, minimum, inv-norm transformed) | GCST90475532 | 0.07 |
| 8592 | Medical abortion | FING00000796 | 0.07 |
| 8593 | Leiomyoma of uterus | FING00000719 | 0.07 |
| 8594 | Left bundle branch block (PheCode 426.32) | GCST90475958 | 0.07 |
| 8595 | Central serous chorioretinopathy | GCST90268400 | 0.07 |
| 8596 | Body mass index | GCST90103751 | 0.07 |
| 8597 | Squamous cell carcinoma (MTAG) | GCST90137412 | 0.07 |
| 8598 | ARL13B levels | GCST90468363 | 0.07 |
| 8599 | F11 levels | GCST90469165 | 0.07 |
| 8600 | Common executive function | GCST90162547 | 0.07 |
| 8601 | RTN4R levels | GCST90470508 | 0.07 |
| 8602 | Cholesterol in Small VLDL | GCST90499746 | 0.07 |
| 8603 | Insomnia | FING00000683 | 0.07 |
| 8604 | Total fatty acid levels | GCST90502710 | 0.07 |
| 8605 | Colon polyp | GCST90018607 | 0.07 |
| 8606 | Insulin pump user (PheCode 250.3) | GCST90475680 | 0.07 |
| 8607 | Other alveolar and parietoalveolar pneumonopathy (PheCode 504) | GCST90476033 | 0.07 |
| 8608 | High light scatter reticulocyte percentage of red cells | GCST90002386 | 0.07 |
| 8609 | Linoleic acid to total fatty acids percentage | GCST90498328 | 0.07 |
| 8610 | CXCL13 levels | GCST90468926 | 0.07 |
| 8611 | CHGB levels | GCST90468742 | 0.07 |
| 8612 | Atopic dermatitis | GCST90027161 | 0.07 |
| 8613 | Chronic obstructive pulmonary disease in ever smokers | GCST90016588 | 0.07 |
| 8614 | Serum 25-Hydroxyvitamin D levels | GCST90000614 | 0.07 |
| 8615 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T271 | ECGU000271 | 0.07 |
| 8616 | Nontoxic nodular goiter | endocrine/metabolic | UKBB00000529 | 0.07 |
| 8617 | AGRP levels | GCST90240217 | 0.07 |
| 8618 | MMP9/PLTP ratio | GCST90315471 | 0.07 |
| 8619 | Disorders of eyelid, lacrimal system and orbit | FING00000439 | 0.07 |
| 8620 | IDP SWI T2star left pallidum | GCST90003869 | 0.07 |
| 8621 | IL2RB levels | GCST90469586 | 0.07 |
| 8622 | AmygNuclei rh volume Central-nucleus | GCST90002662 | 0.07 |
| 8623 | IDP dMRI TBSS ISOVF Cingulum cingulate gyrus R | GCST90004511 | 0.07 |
| 8624 | ANXA4/CA13 ratio | GCST90313290 | 0.07 |
| 8625 | Falling risk | GCST90012857 | 0.07 |
| 8626 | Triglycerides in large LDL (UKB data field 23536) | GCST90269633 | 0.07 |
| 8627 | Ambidextrousness | GCST90013420 | 0.07 |
| 8628 | Obesity (PheCode 278.1) | GCST90475762 | 0.07 |
| 8629 | SEMA3G levels | GCST90242746 | 0.07 |
| 8630 | Other and/or unspecified nontoxic goitre | FING00000958 | 0.07 |
| 8631 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T209 | ECGU000209 | 0.07 |
| 8632 | PLB1 levels | GCST90470253 | 0.07 |
| 8633 | Sphingomyelin levels | GCST90092982 | 0.07 |
| 8634 | PIK3IP1/TNFRSF1A ratio | GCST90315653 | 0.07 |
| 8635 | TBCC/WWP2 ratio | GCST90315911 | 0.07 |
| 8636 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T176 | ECGU000176 | 0.07 |
| 8637 | NTN4 levels | GCST90242049 | 0.07 |
| 8638 | CD58/IL10RB ratio | GCST90313850 | 0.07 |
| 8639 | T1 FreeSurfer a2009s lh S central thickness | GCST90384786 | 0.07 |
| 8640 | PMVK/RHOC ratio | GCST90315697 | 0.07 |
| 8641 | TGFBR2 levels | GCST90470847 | 0.07 |
| 8642 | Monounsaturated fatty acid levels | GCST90502346 | 0.07 |
| 8643 | Transient ischemic attack | FING00001375 | 0.07 |
| 8644 | Pure hyperglyceridaemia | FING00001231 | 0.07 |
| 8645 | CDKN2D/FOXO1 ratio | GCST90313985 | 0.07 |
| 8646 | White blood cell count | GCST90002407 | 0.07 |
| 8647 | Serum 25-Hydroxyvitamin D levels (conditioned on BMI) | GCST90000616 | 0.07 |
| 8648 | Otitis media (PheCode 381.1) | GCST90475903 | 0.07 |
| 8649 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T272 | ECGU000272 | 0.07 |
| 8650 | GMPR levels | GCST90469368 | 0.07 |
| 8651 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T181 | ECGA000181 | 0.07 |
| 8652 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T453 | ECGA000453 | 0.07 |
| 8653 | DIABLO/MITD1 ratio | GCST90314467 | 0.07 |
| 8654 | TNFRSF1B levels | GCST90012026 | 0.07 |
| 8655 | Hypercholesterolemia | endocrine/metabolic | UKBB00000332 | 0.07 |
| 8656 | Histidine levels | GCST90497479 | 0.07 |
| 8657 | Clonal haematopoiesis of indeterminate potential (TET2 mutation) | GCST90165281 | 0.07 |
| 8658 | Cholesterol in very small VLDL (UKB data field 23519) | GCST90269616 | 0.07 |
| 8659 | PODXL2/SEZ6L ratio | GCST90315702 | 0.07 |
| 8660 | Feeling tense | GCST006952 | 0.07 |
| 8661 | IDP dMRI TBSS FA Anterior limb of internal capsule L | GCST90003894 | 0.07 |
| 8662 | NOMO1 levels | GCST90470060 | 0.07 |
| 8663 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T421 | ECGU000421 | 0.07 |
| 8664 | GLT25D1 levels | GCST90426421 | 0.07 |
| 8665 | Congestive heart failure (CHF) NOS (PheCode 428.1) | GCST90475982 | 0.07 |
| 8666 | Blood cell traits latent factor 14 (red cell) | GCST90559256 | 0.07 |
| 8667 | Other neurological diseases | FING00001074 | 0.07 |
| 8668 | Unruptured cerebral aneurysm | GCST90018596 | 0.07 |
| 8669 | DOK2/LACTB2 ratio | GCST90314532 | 0.07 |
| 8670 | CD5/TNFRSF9 ratio | GCST90313862 | 0.06 |
| 8671 | F8 levels | GCST90240725 | 0.06 |
| 8672 | LAYN/PTPRN2 ratio | GCST90315290 | 0.06 |
| 8673 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T185 | ECGA000185 | 0.06 |
| 8674 | FCGR2B/NOS3 ratio | GCST90314794 | 0.06 |
| 8675 | PLXNA4/SPRY2 ratio | GCST90315687 | 0.06 |
| 8676 | CSF1/SEMA3F ratio | GCST90314288 | 0.06 |
| 8677 | DSG3/SPINK5 ratio | GCST90314561 | 0.06 |
| 8678 | PLSCR3 levels | GCST90470261 | 0.06 |
| 8679 | Viral and other specified intestinal infections | FING00001432 | 0.06 |
| 8680 | Cognitive processing speed | GCST90446168 | 0.06 |
| 8681 | Length of mobile phone use | Electronic device use | UKBB00000403 | 0.06 |
| 8682 | Cholesterol to Total Lipids in Medium LDL percentage | GCST90498723 | 0.06 |
| 8683 | Polycystic ovarian syndrome, broad definition | FING00001183 | 0.06 |
| 8684 | Aspartate aminotransferase levels | GCST90018724 | 0.06 |
| 8685 | LSIL lesion of the cervix uteri | FING00000732 | 0.06 |
| 8686 | Anxiety, nerves or generalized anxiety disorder | Mental distress | UKBB00000039 | 0.06 |
| 8687 | ASS1 levels | GCST90468380 | 0.06 |
| 8688 | Calculus of kidney and ureter | Urolithiasis | UKBB00000116 | 0.06 |
| 8689 | Duration to complete alphanumeric path task (baseline) | GCST90565839 | 0.06 |
| 8690 | Prescriptions - opioid analgesic|selective serotonin re-uptake inhibitor|norepinephrine re-uptake inhibitor | UKBB00000694 | 0.06 |
| 8691 | Prescriptions - tramadol | opioid analgesic,selective serotonin re-uptake inhibitor,norepinephrine re-uptake inhibitor | UKBB00000706 | 0.06 |
| 8692 | Histidine levels | GCST90243404 | 0.06 |
| 8693 | IDP dMRI TBSS OD Anterior limb of internal capsule R | GCST90004418 | 0.06 |
| 8694 | PODXL2 levels | GCST90470279 | 0.06 |
| 8695 | Avocado liking | GCST90094694 | 0.06 |
| 8696 | Prescriptions - alpha1-antagonist|alpha blocker | UKBB00000659 | 0.06 |
| 8697 | HNRNPAB levels | GCST90088693 | 0.06 |
| 8698 | IL6ST/LIFR ratio | GCST90315166 | 0.06 |
| 8699 | ECHDC3 levels | GCST90469062 | 0.06 |
| 8700 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T125 | ECGU000125 | 0.06 |
| 8701 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T210 | ECGU000210 | 0.06 |
| 8702 | Fed-up feelings | Mental health | UKBB00000242 | 0.06 |
| 8703 | FLT4/ICAM2 ratio | GCST90314860 | 0.06 |
| 8704 | Cholesteryl esters to total lipids ratio in small HDL | GCST90092947 | 0.06 |
| 8705 | Other intervertebral disk disorders | Other dorsopathies | UKBB00000612 | 0.06 |
| 8706 | SORT1/VSIR ratio | GCST90315870 | 0.06 |
| 8707 | 1-methylhistidine levels | GCST90199691 | 0.06 |
| 8708 | Baked/steamed fish liking | GCST90094696 | 0.06 |
| 8709 | Polyunsaturated fatty acid levels | GCST90502623 | 0.06 |
| 8710 | Idiopathic pulmonary fibrosis | GCST90399720 | 0.06 |
| 8711 | Internal derangement of knee | injuries & poisonings | UKBB00000368 | 0.06 |
| 8712 | RAB6A levels | GCST90470412 | 0.06 |
| 8713 | UGDH levels | GCST90471006 | 0.06 |
| 8714 | LAMP3 levels | GCST90469735 | 0.06 |
| 8715 | Alkylphosphatidylcholine (O-16:0/16:0) levels | GCST90024913 | 0.06 |
| 8716 | IDP T1 FAST ROIs R temporal pole | GCST90002466 | 0.06 |
| 8717 | REG1B levels | GCST90470448 | 0.06 |
| 8718 | Hematocrit | GCST90278634 | 0.06 |
| 8719 | IDP dMRI ProbtrackX ISOVF str r | GCST90004549 | 0.06 |
| 8720 | GZMA/GZMB ratio | GCST90315007 | 0.06 |
| 8721 | KLK8 levels | GCST90422316 | 0.06 |
| 8722 | PROK1 levels | GCST90470336 | 0.06 |
| 8723 | Cholesterol levels in medium VLDL | GCST90092916 | 0.06 |
| 8724 | Calculus of kidney (PheCode 594.1) | GCST90476145 | 0.06 |
| 8725 | Triglyceride levels in large HDL | GCST90092854 | 0.06 |
| 8726 | MPHOSPH8/USP8 ratio | GCST90315479 | 0.06 |
| 8727 | red cell diameter width (RDW, maximum, inv-norm transformed) | GCST90476355 | 0.06 |
| 8728 | Total Lipids in Medium LDL | GCST90498800 | 0.06 |
| 8729 | Right-hemisphere visual network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302777 | 0.06 |
| 8730 | PDGFA/PLA2G4A ratio | GCST90315615 | 0.06 |
| 8731 | F9/PROC ratio | GCST90314748 | 0.06 |
| 8732 | Monoclonal gammopathy of undetermined significance | GCST90624745 | 0.06 |
| 8733 | PYDC1 levels | GCST90470397 | 0.06 |
| 8734 | Internal derangement of knee | FING00000684 | 0.06 |
| 8735 | GAST levels | GCST90469307 | 0.06 |
| 8736 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T172 | ECGA000172 | 0.06 |
| 8737 | AMBP/RARRES2 ratio | GCST90313256 | 0.06 |
| 8738 | X-21285 levels | GCST90200576 | 0.06 |
| 8739 | Coffee max liking | GCST90094739 | 0.06 |
| 8740 | Herring liking | GCST90094781 | 0.06 |
| 8741 | ITGB1BP2/WASF1 ratio | GCST90315224 | 0.06 |
| 8742 | MANF/SNX9 ratio | GCST90315368 | 0.06 |
| 8743 | T1 FreeSurfer a2009s rh G cuneus area | GCST90384900 | 0.06 |
| 8744 | F-cooking vegetables liking (derived food-liking factor) | GCST90094743 | 0.06 |
| 8745 | DSG3 levels | GCST90469043 | 0.06 |
| 8746 | ANGPT1/APP ratio | GCST90313260 | 0.06 |
| 8747 | IDP dMRI TBSS ISOVF External capsule L | GCST90004510 | 0.06 |
| 8748 | IDP dMRI TBSS L2 Superior longitudinal fasciculus R | GCST90004163 | 0.06 |
| 8749 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T431 | ECGU000431 | 0.06 |
| 8750 | GNS levels | GCST90088460 | 0.06 |
| 8751 | NT5C3A/SCRN1 ratio | GCST90315569 | 0.06 |
| 8752 | IDP dMRI ProbtrackX ICVF str l | GCST90004398 | 0.06 |
| 8753 | ENO2/SCRN1 ratio | GCST90314668 | 0.06 |
| 8754 | PNLIPRP1 levels | GCST90470273 | 0.06 |
| 8755 | Never eat sugar vs no eggs, dairy, wheat or sugar restrictions (UKB data field 6144) | GCST90132933 | 0.06 |
| 8756 | APP/TMSB10 ratio | GCST90313332 | 0.06 |
| 8757 | Right-hemisphere somatomotor network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302790 | 0.06 |
| 8758 | Irritable bowel syndrome | GCST90016564 | 0.06 |
| 8759 | TMPRSS5 levels | GCST90470893 | 0.06 |
| 8760 | Phospholipids to total lipids in medium VLDL percentage (UKB data field 23594) | GCST90269691 | 0.06 |
| 8761 | CD7 levels | GCST90468649 | 0.06 |
| 8762 | Fracture of hand or wrist (PheCode 804) | GCST90476281 | 0.06 |
| 8763 | Never eat wheat vs no wheat restrictions (UKB data field 6144) | GCST90132932 | 0.06 |
| 8764 | T1 FreeSurfer BA rh V2 exvivo area | GCST90385557 | 0.06 |
| 8765 | Glucosamine medication | FING00000584 | 0.06 |
| 8766 | Colon cancer (PheCode 153.2) | GCST90475567 | 0.06 |
| 8767 | Phospholipids to total lipids ratio in medium VLDL | GCST90092925 | 0.06 |
| 8768 | DTI TBSS MD Genu of corpus callosum | GCST90384574 | 0.06 |
| 8769 | Volume of right anterior amygdaloid area | GCST90475003 | 0.06 |
| 8770 | Left ventricular end-systolic volume | GCST90268126 | 0.06 |
| 8771 | Duration to first press of snap-button in each round | Reaction time | UKBB00000202 | 0.06 |
| 8772 | Sphingomyelin (d18:1/14:0) levels/Sphingomyelin (d16:1/16:0) levels | GCST90025115 | 0.06 |
| 8773 | Thyroid stimulating hormone levels | GCST90319321 | 0.06 |
| 8774 | CD84/TREML2 ratio | GCST90313919 | 0.06 |
| 8775 | IDP dMRI TBSS OD Pontine crossing tract | GCST90004403 | 0.06 |
| 8776 | White blood cell (leukocyte) count | Blood count | UKBB00000913 | 0.06 |
| 8777 | Hearing difficulty problems background noise (UKB data field 2257) | GCST90042885 | 0.06 |
| 8778 | CLEC4D/MANSC1 ratio | GCST90314112 | 0.06 |
| 8779 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T242 | ECGU000242 | 0.06 |
| 8780 | Vitiligo | FING00001443 | 0.06 |
| 8781 | Left-hemisphere visual network to left-hemisphere somatomotor network white-matter structural connectivity | GCST90302649 | 0.06 |
| 8782 | BCL2L11 levels | GCST90468430 | 0.06 |
| 8783 | Renal tubulo-interstitial diseases | FING00001251 | 0.06 |
| 8784 | SNAP29/VEGFC ratio | GCST90315862 | 0.06 |
| 8785 | 1-stearoyl-gpc (18:0) levels | GCST90199732 | 0.06 |
| 8786 | Campesterol levels | GCST90199725 | 0.06 |
| 8787 | Cholesterol in large LDL (UKB data field 23533) | GCST90269630 | 0.06 |
| 8788 | LPP levels | GCST90469790 | 0.06 |
| 8789 | LYN/YES1 ratio | GCST90315351 | 0.06 |
| 8790 | High light scatter reticulocyte count | Blood count | UKBB00000326 | 0.06 |
| 8791 | Other disorders of intestine | digestive | UKBB00000608 | 0.06 |
| 8792 | IDP T1 FAST ROIs R cerebellum crus II | GCST90002574 | 0.06 |
| 8793 | Alcohol drinker status - Never | Alcohol | UKBB00000022 | 0.06 |
| 8794 | Breast cancer (estrogen-receptor negative) | GCST005076 | 0.06 |
| 8795 | Illnesses of father - Diabetes | Family history | UKBB00000341 | 0.06 |
| 8796 | Phosphatidylcholine levels | GCST90499248 | 0.06 |
| 8797 | LUZP2 levels | GCST90469819 | 0.06 |
| 8798 | HYOU1/PTPRF ratio | GCST90315102 | 0.06 |
| 8799 | Morbid obesity (PheCode 278.11) | GCST90475765 | 0.06 |
| 8800 | C1RL levels | GCST90468492 | 0.06 |
| 8801 | Phospholipids in small HDL (UKB data field 23574) | GCST90269671 | 0.06 |
| 8802 | IL12B levels | GCST90469549 | 0.06 |
| 8803 | ATG4A/TPMT ratio | GCST90313370 | 0.06 |
| 8804 | HBB levels | GCST90025969 | 0.06 |
| 8805 | aparc-a2009s rh area G-precentral | GCST90003399 | 0.06 |
| 8806 | Fracture of shoulder and upper arm | FING00000559 | 0.06 |
| 8807 | ACY1/SCLY ratio | GCST90313165 | 0.06 |
| 8808 | Cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23581) | GCST90269678 | 0.06 |
| 8809 | Body mass index | GCST90446645 | 0.06 |
| 8810 | Phospholipids to total lipids ratio in large LDL | GCST90092865 | 0.06 |
| 8811 | RGS18 levels | GCST90242617 | 0.06 |
| 8812 | T1 FreeSurfer BA lh BA3a exvivo thickness | GCST90385521 | 0.06 |
| 8813 | DTI TBSS MO Corticospinal tract R | GCST90384626 | 0.06 |
| 8814 | IDP dMRI ProbtrackX FA fma | GCST90003935 | 0.06 |
| 8815 | IDP dMRI TBSS ICVF Posterior limb of internal capsule L | GCST90004346 | 0.06 |
| 8816 | RSPO1/RSPO3 ratio | GCST90315790 | 0.06 |
| 8817 | MED18/TBL1X ratio | GCST90315415 | 0.06 |
| 8818 | Hemoglobin A1c levels | GCST90278632 | 0.06 |
| 8819 | Percentage of fucosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP80) | GCST90668524 | 0.06 |
| 8820 | Prescriptions - biguanides|diabetes | UKBB00000671 | 0.06 |
| 8821 | Phosphatidylcholine levels | GCST90092937 | 0.06 |
| 8822 | UBA9475 sp002161235 abundance in stool | GCST90032635 | 0.06 |
| 8823 | Left-hemisphere visual network to right-hemisphere visual network white-matter structural connectivity | GCST90302655 | 0.06 |
| 8824 | Omega-6 fatty acids to total fatty acids percentage | GCST90499203 | 0.06 |
| 8825 | aparc-pial lh area precentral | GCST90003164 | 0.06 |
| 8826 | TACC3/TRIAP1 ratio | GCST90315901 | 0.06 |
| 8827 | High light scatter reticulocyte percentage (UKB data field 30290) | GCST90468077 | 0.06 |
| 8828 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T492 | ECGU000492 | 0.06 |
| 8829 | CALCOCO1/METAP2 ratio | GCST90313606 | 0.06 |
| 8830 | Prescriptions - metformin | biguanides,diabetes | UKBB00000692 | 0.06 |
| 8831 | Types of transport used (excluding work) - Public transport | Physical activity | UKBB00000878 | 0.06 |
| 8832 | SSC4D/TNFSF10 ratio | GCST90315887 | 0.06 |
| 8833 | CA13/QDPR ratio | GCST90313564 | 0.06 |
| 8834 | Estimated glomerular filtration rate, cystain C | Other measurement | UKBB00000210 | 0.06 |
| 8835 | RRAS levels | GCST90470499 | 0.06 |
| 8836 | IL32 levels | GCST90469591 | 0.06 |
| 8837 | EREG/GYS1 ratio | GCST90314701 | 0.06 |
| 8838 | Ever depressed for a whole week | Mental health | UKBB00000214 | 0.06 |
| 8839 | Other disorders of patella | FING00001032 | 0.06 |
| 8840 | Lamb or mutton consumption (UKB data field 1379) | GCST90132998 | 0.06 |
| 8841 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T255 | ECGU000255 | 0.06 |
| 8842 | SUOX levels | GCST90470785 | 0.06 |
| 8843 | PRSS53 levels | GCST90470344 | 0.06 |
| 8844 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 36) | GCST90320855 | 0.06 |
| 8845 | DTI autoptx MD ifo l tract | GCST90385232 | 0.06 |
| 8846 | Cooked vegetable intake | Diet | UKBB00000147 | 0.06 |
| 8847 | PCDH17/PTPRM ratio | GCST90315603 | 0.06 |
| 8848 | FUT8/SPARC ratio | GCST90314893 | 0.06 |
| 8849 | Trouble falling asleep when you first go to bed | GCST90476385 | 0.06 |
| 8850 | Free cholesterol in medium LDL (UKB data field 23542) | GCST90269639 | 0.06 |
| 8851 | BA-exvivo rh volume V1 | GCST90002858 | 0.06 |
| 8852 | Types of physical activity in last 4 weeks - Light DIY (eg: pruning, watering the lawn) | Physical activity | UKBB00000871 | 0.06 |
| 8853 | Posterior diffusion tensor imaging along the perivascular space index | GCST90455545 | 0.06 |
| 8854 | Stenosis and insufficiency of lacrimal passages | FING00001334 | 0.06 |
| 8855 | Omega-6 fatty acid levels | GCST90502519 | 0.06 |
| 8856 | IDP dMRI TBSS MO Cerebral peduncle L | GCST90003967 | 0.06 |
| 8857 | Low density lipoprotein cholesterol levels | GCST90278638 | 0.06 |
| 8858 | High-density lipoprotein levels (MTAG) | GCST90179147 | 0.06 |
| 8859 | Hair colour (natural, before greying) - Light brown | Sun exposure | UKBB00000298 | 0.06 |
| 8860 | Triglycerides in small VLDL | GCST90499917 | 0.06 |
| 8861 | HSPB6/SNCG ratio | GCST90315090 | 0.06 |
| 8862 | CD74 levels | GCST90468647 | 0.06 |
| 8863 | Percentage of invited food questionnaires completed | GCST90012790 | 0.06 |
| 8864 | CPXM1/DKK1 ratio | GCST90314218 | 0.06 |
| 8865 | CRADD/FADD ratio | GCST90314237 | 0.06 |
| 8866 | Cholesterol to total lipids in small VLDL percentage (UKB data field 23600) | GCST90269697 | 0.06 |
| 8867 | Dermatitis and eczema | FING00000402 | 0.06 |
| 8868 | Anaemias | FING00000082 | 0.06 |
| 8869 | Age at onset of walking | GCST90651078 | 0.06 |
| 8870 | IDP dMRI TBSS ISOVF Sagittal stratum R | GCST90004507 | 0.06 |
| 8871 | wg rh intensity-contrast pericalcarine | GCST90003847 | 0.06 |
| 8872 | CLPS/CTRB1 ratio | GCST90314139 | 0.06 |
| 8873 | IDP dMRI TBSS ICVF Pontine crossing tract | GCST90004328 | 0.06 |
| 8874 | Tryptophan betaine levels | GCST90199819 | 0.06 |
| 8875 | Fasting blood glucose | GCST000568 | 0.06 |
| 8876 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T124 | ECGU000124 | 0.06 |
| 8877 | red cell diameter width (RDW, minimum, inv-norm transformed) | GCST90476365 | 0.06 |
| 8878 | Volume of right lateral nucleus | GCST90475039 | 0.06 |
| 8879 | Type 2 diabetes with neurological manifestations (PheCode 250.24) | GCST90475676 | 0.06 |
| 8880 | Esophageal adenocarcinoma | GCST003739 | 0.06 |
| 8881 | Total lipid levels in lipoprotein particles | GCST90500086 | 0.06 |
| 8882 | aparc-a2009s rh thickness G+S-cingul-Ant | GCST90003682 | 0.06 |
| 8883 | Cabbage liking | GCST90094719 | 0.06 |
| 8884 | ANXA1 levels | GCST90240296 | 0.06 |
| 8885 | IDP dMRI TBSS L3 Posterior limb of internal capsule L | GCST90004190 | 0.06 |
| 8886 | AXIN1/NFATC1 ratio | GCST90313415 | 0.06 |
| 8887 | IDP T1 FAST ROIs R cerebellum VIIIa | GCST90002580 | 0.06 |
| 8888 | Mouth/teeth dental problems - None of the above | Mouth | UKBB00000489 | 0.06 |
| 8889 | Conditional arithmetic | Fluid intelligence / reasoning | UKBB00000145 | 0.06 |
| 8890 | PPCDC levels | GCST90470290 | 0.06 |
| 8891 | IDP dMRI ProbtrackX ICVF atr l | GCST90004377 | 0.06 |
| 8892 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502396 | 0.06 |
| 8893 | C8 Carnitine levels in chronic kidney disease | GCST90257680 | 0.06 |
| 8894 | Mean arterial pressure, manual reading | Cardiovascular measurement | UKBB00000442 | 0.06 |
| 8895 | IDP dMRI TBSS MD Inferior cerebellar peduncle L | GCST90004038 | 0.06 |
| 8896 | Clinical LDL cholesterol levels (UKB data field 23404) | GCST90269501 | 0.06 |
| 8897 | GGT1/MME ratio | GCST90314930 | 0.06 |
| 8898 | FEN1 levels | GCST90469213 | 0.06 |
| 8899 | PTS levels | GCST90470390 | 0.06 |
| 8900 | CALCOCO1/PDLIM7 ratio | GCST90313607 | 0.06 |
| 8901 | Hereditary and idiopathic peripheral neuropathy (PheCode 356) | GCST90475844 | 0.06 |
| 8902 | Major depressive disorder (probable) | GCST005904 | 0.06 |
| 8903 | Total cholines levels | GCST90497183 | 0.06 |
| 8904 | Triacylglycerol_54:4_[M+NH4]1+ levels | GCST90060540 | 0.06 |
| 8905 | Charcot foot | FING00000268 | 0.06 |
| 8906 | TFRC levels | GCST90470840 | 0.06 |
| 8907 | HCLS1/TMSB10 ratio | GCST90315043 | 0.06 |
| 8908 | PTPRN2 levels | GCST90470385 | 0.06 |
| 8909 | Body fat percentage (adjusted for testosterone and SHBG) x sex interaction | GCST90432181 | 0.06 |
| 8910 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T429 | ECGU000429 | 0.06 |
| 8911 | aparc-a2009s lh area S-orbital-H-Shaped | GCST90003360 | 0.06 |
| 8912 | IDP T1 FAST ROIs R subcallosal cortex | GCST90002504 | 0.05 |
| 8913 | Disorders of other endocrine glands | FING00000450 | 0.05 |
| 8914 | Red cell distribution width | GCST006804 | 0.05 |
| 8915 | Urinary albumin-to-creatinine ratio | GCST009640 | 0.05 |
| 8916 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T120 | ECGU000120 | 0.05 |
| 8917 | Docosahexaenoic acid levels | GCST90502243 | 0.05 |
| 8918 | Serum creatinine levels | GCST90018759 | 0.05 |
| 8919 | DTI TBSS L2 Superior cerebellar peduncle R | GCST90384488 | 0.05 |
| 8920 | Other disorders of breast | FING00001018 | 0.05 |
| 8921 | IDP T1 FAST ROIs R cerebellum VIIb | GCST90002577 | 0.05 |
| 8922 | IDP dMRI ProbtrackX FA cgc r | GCST90003930 | 0.05 |
| 8923 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 108) | GCST90320671 | 0.05 |
| 8924 | Total Cholesteryl ester levels | GCST90025188 | 0.05 |
| 8925 | Hearing difficulty/problems | Hearing | UKBB00000311 | 0.05 |
| 8926 | Mosaic chromosomal alteration of the X chromosome | GCST90165287 | 0.05 |
| 8927 | Omega-6 fatty acid levels | GCST90502094 | 0.05 |
| 8928 | LEG1 levels | GCST90469753 | 0.05 |
| 8929 | ThalamNuclei rh volume PuI | GCST90002738 | 0.05 |
| 8930 | Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers) | FING00000865 | 0.05 |
| 8931 | CD22/SEMA7A ratio | GCST90313759 | 0.05 |
| 8932 | IDI2 levels | GCST90469505 | 0.05 |
| 8933 | GSTA1/KRT18 ratio | GCST90314993 | 0.05 |
| 8934 | CD83/IL12A_IL12B ratio | GCST90313905 | 0.05 |
| 8935 | EDAR/SPARC ratio | GCST90314588 | 0.05 |
| 8936 | Urine X-24796 levels in chronic kidney disease | GCST90266800 | 0.05 |
| 8937 | wg lh intensity-contrast rostralanteriorcingulate | GCST90003817 | 0.05 |
| 8938 | DTI TBSS L2 External capsule R | GCST90384508 | 0.05 |
| 8939 | IL6ST/TYRO3 ratio | GCST90315170 | 0.05 |
| 8940 | SPOCK2 levels | GCST90242987 | 0.05 |
| 8941 | ZP3 levels | GCST90471105 | 0.05 |
| 8942 | wg rh intensity-contrast lateraloccipital | GCST90003837 | 0.05 |
| 8943 | Triglyceride levels in very large HDL | GCST90132636 | 0.05 |
| 8944 | GALNT7 levels | GCST90469299 | 0.05 |
| 8945 | Cholesteryl esters to total lipids in large LDL percentage (UKB data field 23616) | GCST90269713 | 0.05 |
| 8946 | Spread type: Butter/spreadable butter (UKB data field 1428_1) | GCST90132953 | 0.05 |
| 8947 | Sleep apnea syndrome | GCST90267361 | 0.05 |
| 8948 | Bread intake (UKB data field 1438) | GCST90468162 | 0.05 |
| 8949 | Secondary diabetes mellitus (PheCode 249) | GCST90475655 | 0.05 |
| 8950 | LGMN/SPINT2 ratio | GCST90315324 | 0.05 |
| 8951 | NPDC1/PTGDS ratio | GCST90315549 | 0.05 |
| 8952 | LDL cholesterol | GCST002222 | 0.05 |
| 8953 | Phospholipids to total lipids in medium LDL percentage (UKB data field 23619) | GCST90269716 | 0.05 |
| 8954 | Other localized connective tissue disorders | FING00001066 | 0.05 |
| 8955 | SCRG1 levels | GCST90470554 | 0.05 |
| 8956 | BCAN/NCAN ratio | GCST90313481 | 0.05 |
| 8957 | Illness, injury, bereavement, stress in last 2 years - Financial difficulties | Mental health | UKBB00000338 | 0.05 |
| 8958 | CDC37/PPP1R12A ratio | GCST90313934 | 0.05 |
| 8959 | white blood cell count (WBC, mean, inv-norm transformed) | GCST90476454 | 0.05 |
| 8960 | DTI autoptx FA ifo r tract | GCST90385125 | 0.05 |
| 8961 | Trunk fat mass (UKB data field 23128) | GCST90468180 | 0.05 |
| 8962 | RRM2B/SMAD1 ratio | GCST90315788 | 0.05 |
| 8963 | Alcohol use and misuse (confirmatory factor analysis Factor 22) | GCST90309356 | 0.05 |
| 8964 | ANXA3/HCLS1 ratio | GCST90313282 | 0.05 |
| 8965 | HYOU1/RARRES2 ratio | GCST90315103 | 0.05 |
| 8966 | CNTNAP2/DPP6 ratio | GCST90314168 | 0.05 |
| 8967 | Grapefruit liking | GCST90094774 | 0.05 |
| 8968 | Dementia, including avohilmo | FING00000395 | 0.05 |
| 8969 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T126 | ECGU000126 | 0.05 |
| 8970 | Hot drink temperature | Diet | UKBB00000329 | 0.05 |
| 8971 | aparc-DKTatlas lh area superiorparietal | GCST90003261 | 0.05 |
| 8972 | IDP dMRI TBSS L1 Uncinate fasciculus L | GCST90004120 | 0.05 |
| 8973 | PRTN3/RETN ratio | GCST90315734 | 0.05 |
| 8974 | CD74/DLL1 ratio | GCST90313891 | 0.05 |
| 8975 | IDP T1 FAST ROIs L subcallosal cortex | GCST90002503 | 0.05 |
| 8976 | Major dietary changes in the last 5 years - Yes, because of illness | Diet | UKBB00000422 | 0.05 |
| 8977 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T426 | ECGU000426 | 0.05 |
| 8978 | aparc-a2009s rh volume G-pariet-inf-Supramar | GCST90003024 | 0.05 |
| 8979 | BCAM/PCDH17 ratio | GCST90313475 | 0.05 |
| 8980 | Cholesteryl esters in large LDL (UKB data field 23534) | GCST90269631 | 0.05 |
| 8981 | CALCOCO1/VPS53 ratio | GCST90313612 | 0.05 |
| 8982 | GSTA1/SULT2A1 ratio | GCST90314996 | 0.05 |
| 8983 | TNF/TNFRSF1B ratio | GCST90315942 | 0.05 |
| 8984 | Right-hemisphere visual network to amygdala white-matter structural connectivity | GCST90302786 | 0.05 |
| 8985 | Estimated glomerular filtration rate, serum creatinine + cystain C | Other measurement | UKBB00000211 | 0.05 |
| 8986 | Rheumatoid arthritis | musculoskeletal | UKBB00000757 | 0.05 |
| 8987 | CPA2/ITGB7 ratio | GCST90314207 | 0.05 |
| 8988 | Tyrosine levels | GCST90500156 | 0.05 |
| 8989 | DTI autoptx MD atr r tract | GCST90385223 | 0.05 |
| 8990 | EHMT2 levels | GCST90241442 | 0.05 |
| 8991 | KLK7 levels | GCST90469706 | 0.05 |
| 8992 | Neurociticism | GCST006940 | 0.05 |
| 8993 | Urinary calculus | genitourinary | UKBB00000886 | 0.05 |
| 8994 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T423 | ECGU000423 | 0.05 |
| 8995 | PROS1 levels | GCST90470337 | 0.05 |
| 8996 | GP6/TMSB10 ratio | GCST90314975 | 0.05 |
| 8997 | Any mental disorder | FING00000100 | 0.05 |
| 8998 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T281 | ECGU000281 | 0.05 |
| 8999 | SPON2 levels | GCST90470732 | 0.05 |
| 9000 | Treatment/medication code - simvastatin | Medications | UKBB00000859 | 0.05 |